Recent Advances for Anti-Obesity Agents
The Journal of Korean Diabetes, 2015 Obesity is one of the most significant risk factor for diabetes, cardiovascular disease, malignancy and other chronic diseases. The obesity and its associated conditions is one of the most urgent health concerns worldwide. Lifestyle modifications comprising diet modification, exercise, and behavior therapy are basic to the treatment for obesity ...
C. Kim
openaire +2 more sources
Comparative efficacy and safety of metformin, anti-obesity agents, and myoinositol in improving IVF/ICSI outcomes and reducing ovarian hyperstimulation syndrome in women with polycystic ovary syndrome: a systematic review and network meta-analysis. [PDF]
J Ovarian ResTo compare the efficacy and safety of metformin, anti-obesity agents, and inositol with polycystic ovary syndrome (PCOS) undergoing in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI).
Lin L +5 more
europepmc +2 more sources
Obesity stigma in young children [PDF]
, 2011 The prevalence of obesity has increased over recent years but obesity stigma remains widespread. The main aim of this study was to examine whether the hypothesised rejection of fatness by young children is specific to overweight or common to other ...
Rowlinson, Madaleine
core +6 more sources
Efficacy of anti-obesity agents: a systematic review and network meta-analysis of randomized controlled trials [PDF]
Perspectives In Medical Research, 2023 Background: To conduct a network meta-analysis comparing the safety and efficacy of five anti-obesity drugs approved by the United States Food and Drug Administration (US FDA)-Bupropion/Naltrexone combination (BUP/NLX), Liraglutide (LIRA), Orlistat (ORLI)
Nishant Babubhai Prajapati +3 more
doaj +1 more source
Journal of Obesity & Metabolic Syndrome, 2021 There is a new generation of antiobesity drugs in development or just arriving on the scene. First, setmelanotide has been approved for three of the ultrarare genetic conditions that cause obesity–#8211;pro-opiomelanocortin deficiency, proprotein ...
Donna H. Ryan
doaj +1 more source
Anti-Obesity Drugs: A Review about Their Effects and Safety [PDF]
Diabetes & Metabolism Journal, 2012 The current recommendations for the treatment of obese people include increased physical activity and reduced calories intake. When the behavioral approach is not sufficient, a pharmacologic treatment is recommended.
Jun Goo Kang, Cheol-Young Park
doaj +1 more source
Encapsulated Peptides and Proteins with an Effect on Satiety
Nanomaterials, 2023 The world scenario has undergone a nutritional transition in which some countries have left the reality of malnutrition and now face an epidemic of excess body weight. Researchers have been looking for strategies to reverse this situation.
Rafael O. de A. Costa +4 more
doaj +1 more source
Anti-Obesity Agents on the Horizon
Korean Journal of Family PracticeSeung Hee Kim
openaire +2 more sources
Stilbenes in grape berries and wine and their potential role as anti-obesity agents: A review
, 2021 Background Stilbenes are a group of naturally occurring phenolic compounds. These compounds are synthetized by plants in response of biotic or abiotic stress situations. The major dietary sources of stilbenes for humans are grape berries and wine.
Nawel Benbouguerra +5 more
semanticscholar +1 more source
General practitioners’ beliefs about obesity and their decision to treat [PDF]
, 2013 The current study explored the relationships between GPs‟ beliefs about the cause of obesity and treatment choices. Participants (n = 81) responded to two sets of materials; vignettes featuring obese patients in which the grade and cause of obesity were ...
Hartley, Nicholas Terry
core +6 more sources